middl
east
respiratori
syndrom
coronaviru
merscov
induc
sever
aggrav
respiratori
failur
infect
patient
frequent
result
mechan
ventil
limit
therapeut
antibodi
accumul
lung
tissu
follow
system
administr
inhal
newli
recogn
altern
possibl
better
rout
therapeut
antibodi
pulmonari
diseas
nebul
process
howev
gener
divers
physiolog
stress
thu
therapeut
antibodi
must
resist
stress
remain
stabl
form
minim
aggreg
first
isol
merscov
neutral
antibodi
reactiv
receptorbind
domain
rbd
spike
glycoprotein
increas
stabil
introduc
mutat
complementaritydetermin
region
cdr
antibodi
hcdr
exclud
clone
two
hydrophob
residu
replac
glu
two
residu
replac
asp
four
residu
replac
posit
charg
amino
acid
lcdr
two
leu
residu
replac
val
modif
success
gener
clone
significantli
greater
stabil
equival
reactiv
neutral
activ
follow
nebul
compar
origin
clone
summari
gener
merscov
neutral
human
antibodi
reactiv
recombin
merscov
rbd
protein
deliveri
via
pulmonari
rout
introduc
stabil
mutat
five
cdr
middl
east
respiratori
syndrom
coronaviru
merscov
first
identifi
saudi
arabia
patient
suffer
acut
pneumonia
subsequ
renal
failur
sinc
world
health
organ
report
laboratoryconfirm
case
merscov
infect
differ
countri
around
world
south
korea
record
highest
number
case
outsid
middl
east
despit
resili
effort
throughout
scientif
medic
commun
vaccin
antivir
agent
merscov
current
avail
merscov
larg
kb
envelop
singlestrand
positivesens
rna
viru
viral
genom
encod
four
major
structur
protein
spike
envelop
e
membran
nucleocapsid
n
protein
glycoprotein
major
envelop
protein
interact
cellular
receptor
dipeptidyl
peptidas
entri
host
cell
protein
consist
subunit
receptorbind
domain
rbd
within
subunit
mediat
receptor
bind
wherea
subunit
facilit
membran
fusion
express
varieti
human
cell
includ
fibroblast
intestin
epitheli
cell
hepatocyt
well
lung
parenchyma
interstitium
merscov
detect
respiratori
secret
lower
respiratori
tract
infect
patient
sever
case
merscov
infect
aggrav
respiratori
failur
ultim
result
mechan
ventil
observ
suggest
merscov
viru
primarili
infect
human
respiratori
tract
replic
within
human
airway
epithelium
antibodi
play
crucial
role
prevent
treatment
viral
infect
polysera
taken
recov
patient
vaccin
donor
use
prophylact
agent
hepat
b
rabi
viral
diseas
palivizumab
synagi
medimmun
gaithersburg
md
usa
approv
prophylaxi
rsv
ibalizumabuiyk
trogarzo
tailm
biolog
taiwan
becam
clinic
avail
treatment
human
immunodefici
viru
type
infect
treatmentexperienc
adult
multidrugresist
failur
respond
current
antiretrovir
regimen
respons
ongo
epidem
sever
group
develop
antimerscov
neutral
monoclon
polyclon
antibodi
target
rbd
antibodi
gener
b
cell
deriv
convalesc
patient
nonimmun
human
antibodi
phagedisplay
librari
fulli
human
mice
transchromosom
bovin
hybridoma
mice
immun
merscov
antibodi
potent
inhibit
rbd
bind
receptor
furthermor
therapeut
effect
rbdspecif
neutral
antibodi
evalu
sever
anim
model
includ
mice
human
mice
mice
well
mice
rabbit
rhesu
monkey
merscov
neutral
antibodi
develop
intraven
iv
deliveri
howev
recent
report
indic
amount
antibodi
deliv
lung
tissu
often
quit
limit
follow
system
deliveri
cynomolgu
monkey
bronchoalveolar
lavag
fluid
contain
doseproport
concentr
system
administr
antibodi
concentr
approxim
less
plasma
therefor
deliveri
therapeut
antibodi
lung
tissu
via
inhal
garner
consider
interest
follow
deliveri
via
airway
cetuximab
antiepiderm
growth
factor
receptor
egfr
antibodi
accumul
normal
cancer
tissu
lung
concentr
twice
achiev
iv
deliveri
addit
recent
studi
show
fc
fusion
protein
nanobodi
also
effici
deliv
via
pulmonari
rout
therefor
merscov
neutral
antibodi
may
also
accumul
higher
concentr
follow
deliveri
via
pulmonari
rout
suggest
higher
efficaci
order
pulmonari
deliveri
success
antibodi
must
suffici
stabl
resist
denatur
process
nebul
studi
gener
merscov
neutral
antibodi
deliveri
via
nebul
construct
phagedisplay
librari
two
convalesc
merscovinfect
patient
success
isol
nine
merscov
rbdspecif
neutral
mab
nebul
antibodi
show
signific
aggreg
reduc
reactiv
recombin
glycoprotein
therefor
reduc
number
hydrophob
residu
introduc
solubil
mutat
within
complementaritydetermin
region
cdr
gener
antibodi
resist
aggreg
nebul
retain
merscov
neutral
activ
gener
human
singlechain
variabl
fragment
scfv
phagedisplay
librari
use
peripher
blood
mononuclear
cell
pbmc
isol
two
merscovinfect
convalesc
patient
one
patient
consid
super
spreader
patient
wife
index
patient
previou
report
complex
librari
exceed
colonyform
unit
patient
respect
third
fourth
round
biopan
recombin
merscov
rbd
protein
scfv
clone
retriev
highthroughput
manner
describ
previous
briefli
microcoloni
form
tr
chip
clone
uniqu
v
h
v
k
v
identifi
clone
uniqu
sequenc
identifi
select
clone
encod
uniqu
sequenc
rescu
phage
phage
enzymelink
immunosorb
assay
elisa
analysi
total
uniqu
scfv
clone
highli
reactiv
recombin
merscov
rbd
protein
data
shown
clone
prepar
scfv
fuse
human
fc
scfvhfc
use
eukaryot
express
vector
cell
human
antimerscov
neutral
mab
report
previous
also
prepar
form
use
posit
control
perform
microneutr
assay
test
neutral
activ
identifi
scfv
clone
merscov
among
scfv
clone
potent
inhibit
merscov
replic
halfmaxim
inhibitori
concentr
ic
valu
rang
tabl
next
test
stabil
clone
nebul
nebul
fusion
protein
concentr
phosphatebuff
salin
pb
use
vibrat
mesh
nebul
collect
aerosol
collect
sampl
show
clearli
visibl
aggreg
data
shown
centrifug
remov
aggreg
materi
repeat
elisa
analysi
compar
reactiv
preand
postnebul
scfvhfc
nine
clone
show
significantli
reduc
reactiv
recombin
glycoprotein
nebul
figur
select
clone
antibodi
exhibit
lowest
ic
valu
among
antibodi
deriv
patient
respect
perform
studi
studi
mechan
underli
inhibit
viral
infect
cell
antibodi
mix
recombin
glycoprotein
ad
cell
scfvhfc
nearli
complet
block
bind
recombin
glycoprotein
cell
equimolar
concentr
nm
figur
indic
antibodi
block
initi
interact
viru
cell
enhanc
stabil
clone
sought
introduc
mutat
cdr
except
heavi
chain
replac
hydrophob
residu
hydrophil
residu
defin
cdr
accord
intern
immunogenet
inform
system
imgt
target
phe
ile
leu
val
met
trp
tyr
defin
hydrophob
amino
acid
previou
report
clone
hydrophob
residu
select
random
figur
six
residu
design
encod
wildtyp
amino
acid
asp
glu
redund
amino
acid
depend
degener
codon
first
scfv
phagedisplay
librari
tabl
prefer
neg
charg
amino
acid
posit
charg
amino
acid
lower
isoelectr
point
antibodi
may
reduc
nonspecif
vivo
clearanc
random
scfv
phagedisplay
librari
complex
colonyform
unit
exceed
theoret
complex
nucleotid
level
two
round
biopan
recombin
merscov
rbd
protein
randomli
rescu
phage
clone
perform
phage
elisa
eleven
scfv
clone
show
reactiv
recombin
merscov
rbd
protein
similar
higher
origin
clone
clone
harbor
replac
ten
clone
one
residu
replac
either
asp
glu
redund
amino
acid
depend
degener
codon
test
stabil
clone
nebul
scfvhfc
fusion
protein
prepar
subject
elisa
follow
nebul
reactiv
scfvhfc
recombin
glycoprotein
much
less
affect
nebul
scfvhfc
howev
reactiv
clone
somewhat
reduc
compar
clone
figur
one
residu
replac
either
asp
glu
redund
amino
acid
depend
degener
codon
test
stabil
clone
nebul
scfvhfc
fusion
protein
prepar
subject
elisa
follow
nebul
reactiv
scfvhfc
recombin
glycoprotein
much
less
affect
nebul
scfvhfc
howev
reactiv
clone
somewhat
reduc
compar
clone
figur
parallel
experi
use
clone
prepar
random
scfv
phagedisplay
librari
select
seven
clone
none
clone
success
express
scfvhfc
format
less
prevent
us
conduct
studi
clone
data
shown
first
random
librari
six
hydrophob
amino
acid
residu
asterisk
target
second
librari
prepar
clone
random
nine
amino
acid
residu
asterisk
random
first
random
librari
b
eight
amino
acid
residu
asterisk
lcdr
clone
select
second
librari
random
third
random
librari
achiev
stabil
affin
matur
gener
second
scfv
phagedisplay
librari
use
strategi
random
nine
residu
clone
introduc
neg
charg
residu
figur
tabl
prolin
exclud
random
prolin
frequent
form
uniqu
structur
essenti
antibodi
reactiv
second
random
scfv
phagedisplay
librari
complex
colonyform
unit
exceed
theoret
complex
nucleotid
level
second
round
biopan
recombin
merscov
rbd
protein
select
clone
display
greater
reactiv
recombin
merscov
rbd
protein
clone
phage
elisa
analysi
clone
contain
replac
six
residu
figur
show
highest
intrins
solubl
score
among
test
clone
interestingli
two
residu
replac
asp
four
residu
replac
posit
charg
amino
acid
allow
degener
codon
figur
prepar
scfvhfc
fusion
protein
use
eukaryot
express
system
nebul
reactiv
scfvhfc
recombin
glycoprotein
less
affect
either
scfvhfc
figur
b
addit
reactiv
scfvhfc
enhanc
compar
scfvhfc
compar
scfvhfc
next
prepar
use
eukaryot
express
system
compar
reactiv
immunoglobulin
recombin
glycoprotein
nebul
expect
reactiv
better
retain
follow
nebul
figur
also
test
whether
effect
block
interact
recombin
glycoprotein
cell
nebul
flow
cytometri
analysi
found
almost
complet
block
bind
recombin
glycoprotein
cell
follow
nebul
fail
block
interact
nebul
figur
first
random
librari
six
hydrophob
amino
acid
residu
asterisk
target
second
librari
prepar
clone
random
nine
amino
acid
residu
asterisk
random
first
random
librari
b
eight
amino
acid
residu
asterisk
lcdr
clone
select
second
librari
random
third
random
librari
parallel
experi
use
clone
prepar
random
scfv
phagedisplay
librari
select
seven
clone
none
clone
success
express
scfvhfc
format
less
prevent
us
conduct
studi
clone
data
shown
achiev
stabil
affin
matur
gener
second
scfv
phagedisplay
librari
use
strategi
random
nine
residu
clone
introduc
neg
charg
residu
figur
tabl
prolin
exclud
random
prolin
frequent
form
uniqu
structur
essenti
antibodi
reactiv
second
random
scfv
phagedisplay
librari
complex
colonyform
unit
exceed
theoret
complex
nucleotid
level
second
round
biopan
recombin
merscov
rbd
protein
select
clone
display
greater
reactiv
recombin
merscov
rbd
protein
clone
phage
elisa
analysi
clone
contain
replac
six
residu
figur
show
highest
intrins
solubl
score
among
test
clone
interestingli
two
residu
replac
asp
four
residu
replac
posit
charg
amino
acid
allow
degener
codon
figur
prepar
scfvhfc
fusion
protein
use
eukaryot
express
system
nebul
reactiv
scfvhfc
recombin
glycoprotein
less
affect
either
scfvhfc
figur
b
addit
reactiv
scfvhfc
enhanc
compar
scfvhfc
compar
scfvhfc
next
prepar
igg
use
eukaryot
express
system
compar
reactiv
immunoglobulin
recombin
glycoprotein
nebul
expect
reactiv
igg
better
retain
follow
nebul
igg
figur
also
test
whether
igg
effect
block
interact
recombin
glycoprotein
cell
nebul
flow
cytometri
analysi
found
igg
almost
complet
block
bind
recombin
glycoprotein
cell
follow
nebul
igg
fail
block
interact
nebul
figur
igg
show
somewhat
reduc
reactiv
nebul
sought
confer
addit
stabil
random
eight
hydrophob
residu
lcdr
use
random
scheme
achiev
colonyform
unit
third
random
scfv
phagedisplay
librari
exceed
theoret
complex
figur
two
round
biopan
recombin
merscov
rbd
protein
select
clone
phage
elisa
reactiv
similar
greater
sanger
sequenc
reveal
singl
clone
repetit
select
select
clone
harbor
replac
valin
figur
prepar
igg
use
eukaryot
express
system
analyz
characterist
use
elisa
sizeexclus
highperform
liquid
chromatographi
sehplc
dynam
light
scatter
dl
plaqu
reduct
neutral
test
prnt
elisa
reveal
notic
declin
reactiv
recombin
glycoprotein
igg
igg
nebul
yet
chang
reactiv
igg
nebul
neglig
figur
show
somewhat
reduc
reactiv
nebul
sought
confer
addit
stabil
random
eight
hydrophob
residu
lcdr
use
random
scheme
achiev
colonyform
unit
third
random
scfv
phagedisplay
librari
exceed
theoret
complex
figur
two
round
biopan
recombin
merscov
rbd
protein
select
clone
phage
elisa
reactiv
similar
greater
sanger
sequenc
reveal
singl
clone
repetit
select
select
clone
harbor
replac
valin
figur
prepar
use
eukaryot
express
system
analyz
characterist
use
elisa
sizeexclus
highperform
liquid
chromatographi
sehplc
dynam
light
scatter
dl
plaqu
reduct
neutral
test
elisa
reveal
notic
declin
reactiv
recombin
glycoprotein
nebul
yet
chang
reactiv
nebul
neglig
figur
reactiv
antimerscov
antibodi
nebul
follow
nebul
concentr
mgml
aerosol
collect
subject
elisa
recombin
glycoproteinco
microtit
plate
incub
prenebul
postnebul
b
c
hrpconjug
antihuman
igg
antibodi
use
probe
abt
use
substrat
experi
perform
duplic
data
indic
mean
sd
sehplc
analysi
highmolecular
weight
aggreg
detect
postnebul
sampl
howev
aggreg
found
postnebul
sampl
tabl
figur
accord
sehplc
data
dl
analysi
show
nebul
process
convert
respect
highmolecularweight
aggreg
nebul
result
aggreg
tabl
figur
sehplc
analysi
highmolecular
weight
aggreg
detect
postnebul
sampl
igg
howev
aggreg
found
postnebul
sampl
igg
tabl
figur
accord
sehplc
data
dl
analysi
show
nebul
process
convert
igg
respect
highmolecularweight
aggreg
nebul
result
aggreg
igg
tabl
figur
neutral
activ
preand
postnebul
evalu
use
live
merscov
antibodi
mix
live
merscov
antibodyviru
mixtur
allow
infect
vero
cell
exhibit
effect
inhibitori
activ
merscov
valu
respect
nebul
show
valu
similar
prenebul
valu
dramat
increas
follow
nebul
figur
neutral
activ
preand
postnebul
igg
evalu
prnt
pulmonari
deliveri
effici
drug
deliveri
rout
lung
parenchyma
deliveri
sometim
exceed
effici
system
inject
deliv
drug
via
airway
aerosol
contain
drug
gener
nebul
howev
physic
stress
nebul
often
caus
protein
instabl
affect
integr
molecular
structur
frequent
result
fragment
aggreg
aggreg
therapeut
protein
major
concern
contribut
immunogen
frequent
caus
advers
event
decreas
drug
efficaci
infus
reaction
cytokin
releas
syndrom
anaphylaxi
vibrat
mesh
nebul
design
protein
deliveri
gener
limit
variat
temperatur
concentr
surfac
tension
effect
stabil
protein
least
among
nebul
type
nebul
also
produc
uniform
size
particl
flow
rate
also
benefici
maintain
stabil
biolog
product
reduc
immunogen
therapeut
protein
maintain
stabil
nativ
protein
conform
well
minim
format
highmolecular
weight
speci
crucial
therefor
engin
protein
render
stabl
pulmonari
deliveri
import
recent
studi
trival
nanobodi
rsv
f
protein
pulmonari
deliveri
effici
drug
deliveri
rout
lung
parenchyma
deliveri
sometim
exceed
effici
system
inject
deliv
drug
via
airway
aerosol
contain
drug
gener
nebul
howev
physic
stress
nebul
often
caus
protein
instabl
affect
integr
molecular
structur
frequent
result
fragment
aggreg
aggreg
therapeut
protein
major
concern
contribut
immunogen
frequent
caus
advers
event
decreas
drug
efficaci
infus
reaction
cytokin
releas
syndrom
anaphylaxi
vibrat
mesh
nebul
design
protein
deliveri
gener
limit
variat
temperatur
concentr
surfac
tension
effect
stabil
protein
least
among
nebul
type
nebul
also
produc
uniform
size
particl
flow
rate
also
benefici
maintain
stabil
biolog
product
reduc
immunogen
therapeut
protein
maintain
stabil
nativ
protein
conform
well
minim
format
highmolecular
weight
speci
crucial
therefor
engin
protein
render
stabl
pulmonari
deliveri
import
recent
studi
trival
nanobodi
rsv
f
protein
success
deliv
directli
lung
nebul
neutral
rsv
newborn
lamb
case
framework
region
nanobodi
contain
hydrophil
residu
observ
human
v
h
domain
therebi
increas
stabil
nanobodi
studi
focus
cdr
sequenc
cdr
loop
close
relat
fold
stabil
antibodi
cdr
loop
frequent
possess
hydrophob
residu
facilit
high
bind
affin
howev
solventexpos
hydrophob
residu
also
impact
antibodi
stabil
aggreg
increas
solubl
counterbal
impact
hydrophob
residu
requir
antibodi
bind
solubil
residu
introduc
either
edg
cdr
loop
within
cdr
furthermor
neg
charg
substitut
mutat
within
cdr
use
prevent
aggreg
studi
employ
strategi
reduc
number
hydrophob
residu
increas
number
charg
residu
cdr
result
success
enhanc
stabil
merscov
neutral
antibodi
final
optim
antibodi
show
limit
protein
aggreg
nebul
biolog
potenc
well
maintain
deliveri
expect
formul
surfact
polysorb
may
prevent
aggreg
antibodi
nebul
test
whether
antibodi
provid
better
efficaci
deliv
via
pulmonari
rout
via
system
inject
anim
model
progress
pulmonari
failur
essenti
case
mous
model
infect
mice
exhibit
central
nervou
system
multiorgan
failur
sever
pulmonari
symptom
recent
mice
develop
show
progress
pulmonari
manifest
infect
mouseadapt
strain
thu
futur
studi
test
efficaci
deliv
via
pulmonari
rout
mice
studi
provid
human
sampl
approv
institut
ethic
review
board
seoul
nation
univers
hospit
irb
approv
number
written
inform
consent
obtain
particip
pbmc
isol
two
merscovinfect
convalesc
patient
use
ficollpaqu
densiti
gradient
medium
ge
healthcar
pittsburgh
pa
usa
describ
previous
pbmc
subject
total
rna
isol
use
tri
reagent
invitrogen
carlsbad
ca
usa
follow
manufactur
instruct
rna
use
synthes
cdna
use
superscript
iii
firststrand
synthesi
system
invitrogen
oligo
dt
primer
accord
manufactur
instruct
use
cdna
templat
gene
encod
variabl
region
heavi
light
chain
v
h
v
k
v
amplifi
use
construct
human
scfv
phagedisplay
librari
describ
previous
construct
first
random
librari
set
degener
ultram
dna
oligonucleotid
integr
dna
technolog
coralvil
ia
usa
encod
residu
clone
v
chemic
synthes
contain
either
codon
encod
wildtyp
amino
acid
gak
degener
codon
residu
tabl
gene
fragment
v
hc
encod
residu
clone
amplifi
pcr
use
primer
set
tabl
thermal
cycler
biorad
carlsbad
ca
usa
pcr
condit
follow
preliminari
denatur
c
min
follow
cycl
c
c
c
final
extens
conduct
min
c
electrophoresi
agaros
gel
pcr
product
purifi
use
qiaquick
gel
extract
kit
qiagen
inc
valencia
ca
usa
accord
manufactur
instruct
purifi
v
v
hc
gene
fragment
mix
concentr
ng
subject
linker
pcr
use
primer
set
tabl
thermal
cycler
yield
v
fragment
pcr
condit
follow
preliminari
denatur
c
min
follow
cycl
c
c
c
reaction
end
extens
step
min
c
gene
fragment
encod
v
l
v
clone
amplifi
pcr
use
primer
set
tabl
pcr
condit
describ
amplif
v
hc
v
v
fragment
subject
electrophoresi
agaros
gel
excis
band
purifi
use
qiaquick
gel
extract
kit
purifi
v
v
fragment
use
synthesi
scfv
gene
scfv
use
pcr
describ
previous
amplifi
scfv
fragment
purifi
clone
phagemid
vector
describ
construct
second
random
librari
set
degener
ultram
dna
oligonucleotid
encod
residu
clone
v
chemic
synthes
contain
either
codon
encod
wildtyp
amino
acid
gak
degener
codon
residu
tabl
exclud
previous
random
residu
v
v
hc
gene
fragment
mix
equal
ratio
ng
subject
linker
pcr
use
primer
set
tabl
thermal
cycler
yield
v
gene
fragment
describ
v
gene
fragment
purifi
describ
subject
linker
pcr
v
fragment
yield
scfv
gene
fragment
clone
phagemid
vector
describ
construct
third
random
librari
two
set
degener
ultram
dna
oligonucleotid
length
nucleotid
chemic
synthes
one
set
encod
residu
clone
v
ln
one
encod
clone
v
lc
degener
oligonucleotid
contain
either
codon
encod
wildtyp
amino
acid
gak
degener
codon
residu
tabl
v
ln
v
lc
gene
fragment
ng
subject
linker
pcr
use
primer
set
tabl
thermal
cycler
produc
vl
gene
fragment
use
pcr
condit
describ
amplif
v
gene
fragment
gene
fragment
encod
v
h
vh
amplifi
pcr
use
primer
set
tabl
use
pcr
condit
use
amplif
v
hc
gene
fragment
describ
purif
vl
vh
gene
fragment
use
produc
scfv
gene
fragment
clone
phagemid
vector
describ
human
scfv
phagedisplay
librari
subject
four
round
biopan
recombin
merscov
rbd
protein
sino
biolog
inc
beij
china
describ
previous
briefli
scfv
phagedisplay
librari
phage
ad
recombin
merscov
rbd
protein
conjug
magnet
bead
dynabead
epoxi
invitrogen
incub
rotat
h
c
bead
wash
vv
sigmaaldrich
st
loui
mo
usa
pb
pbst
first
round
biopan
number
wash
increas
three
round
phage
bound
bead
elut
neutral
allow
infect
e
coli
new
england
biolab
ipswich
usa
rescu
describ
previous
first
random
scfv
librari
subject
two
round
biopan
recombin
merscov
rbd
protein
scfv
phagedisplay
librari
phage
ad
recombin
merscov
rbd
protein
conjug
magnet
bead
incub
rotat
h
c
bead
wash
pbst
three
time
pbst
first
second
round
biopan
respect
round
wash
bound
phage
elut
rescu
describ
first
round
biopan
second
third
random
scfv
librari
scfv
phagedisplay
librari
phage
ad
recombin
merscov
rbd
protein
conjug
magnet
bead
incub
rotat
h
c
wash
three
time
pbst
bound
phage
elut
rescu
describ
second
round
biopan
second
third
random
scfv
librari
recombin
merscov
rbd
protein
conjug
nonmagnet
bead
nacalai
san
diego
ca
usa
follow
manufactur
instruct
scfv
phagedisplay
librari
phage
ad
recombin
merscov
rbd
protein
conjug
magnet
bead
incub
rotat
h
c
wash
three
time
pbst
magnet
bead
resuspend
pb
transfer
microtub
microtub
afa
fiber
preslit
snapcap
covari
woburn
usa
along
recombin
merscov
rbd
proteinconjug
nonmagnet
bead
resuspend
pb
concentr
bead
mixtur
subject
ultrasound
wash
step
use
ultrason
covari
follow
condit
duti
factor
df
peak
incid
power
pip
w
cyclesburst
min
c
ultrason
magnet
bead
transfer
microcentrifug
tube
wash
three
time
pbst
bound
phage
elut
rescu
describ
fourth
round
biopan
human
scfv
phagedisplay
librari
plasmid
dna
obtain
overnight
cultur
e
coli
cell
subject
highthroughput
retriev
scfv
clone
truerepertoir
analysi
describ
previous
celem
seoul
korea
select
reactiv
clone
recombin
merscov
rbd
protein
scfv
gene
obtain
truerepertoir
clone
vector
use
transform
e
coli
cell
overnight
cultur
phage
rescu
individu
coloni
use
helper
phage
subject
phage
elisa
describ
previous
microtit
plate
costar
cambridg
usa
coat
ng
recombin
merscov
rbd
protein
coat
buffer
sodium
bicarbon
ph
c
overnight
well
block
wv
bovin
serum
albumin
bsa
thermo
scientif
waltham
usa
dissolv
pb
h
c
cultur
supernat
contain
scfvdisplay
phage
rescu
individu
coloni
ad
well
incub
h
c
microtit
plate
wash
three
time
pbst
horseradish
peroxidas
hrp
conjug
monoclon
antibodi
ge
healthcar
bsapb
ad
well
plate
incub
h
c
wash
three
time
pbst
acid
solut
thermo
scientif
use
substrat
hrp
absorb
measur
nm
multiskan
ascent
micropl
reader
labsystem
helsinki
finland
select
reactiv
clone
random
librari
phage
elisa
perform
describ
previous
use
recombin
merscov
rbd
proteinco
microtit
plate
nucleotid
sequenc
posit
scfv
clone
determin
sanger
sequenc
cosmogenetech
seoul
korea
gene
encod
select
scfv
clone
clone
modifi
mammalian
express
vector
contain
higg
fc
region
hfc
cterminu
describ
previous
express
vector
transfect
cell
invitrogen
fusion
protein
purifi
protein
affin
chromatographi
describ
previous
express
igg
gene
encod
v
h
v
l
amplifi
phage
clone
clone
mammalian
express
vector
transfect
cell
igg
purifi
protein
affin
chromatographi
describ
previous
eluat
contain
igg
subject
gel
filtrat
chromatographi
total
mg
igg
inject
flow
rate
mlmin
purifi
gel
filtrat
use
column
pack
superdex
pg
ph
pure
ge
healthcar
chromatogram
record
uv
absorb
nm
fraction
contain
igg
pool
collect
criteria
concentr
microtit
plate
costar
coat
ng
recombin
glycoprotein
coat
buffer
c
overnight
well
block
bsapb
h
c
nebul
nonnebul
scfvhfc
igg
serial
dilut
dilut
start
nm
scfvhfc
fusion
protein
nm
igg
block
buffer
ad
individu
well
incub
h
c
microtit
plate
wash
three
time
pbst
hrpconjug
rabbit
antihuman
igg
antibodi
invitrogen
block
buffer
ad
well
plate
incub
h
c
wash
three
time
pbst
acid
solut
thermo
scientif
use
substrat
absorb
measur
nm
use
micropl
spectrophotomet
multiskan
go
thermo
scientif
nebul
aerogen
pro
aerogen
galway
ireland
use
experi
follow
manufactur
instruct
nebul
contain
ml
scfvhfc
fusion
protein
igg
antibodi
place
top
conic
tube
spl
life
scienc
pocheon
korea
nebul
concentr
either
mgml
pb
viru
access
number
obtain
korea
nation
institut
health
kindli
provid
dr
sung
soon
kim
propag
vero
cell
atcc
dulbecco
modifi
eagl
medium
dmem
welgen
gyeongsan
republ
korea
presenc
fetal
bovin
serum
gibco
cell
grown
flask
inocul
merscov
incub
c
co
environ
day
inocul
virus
harvest
store
c
viru
titer
determin
via
tcid
assay
neutral
assay
perform
previous
describ
briefli
vero
cell
seed
plate
cellswel
optipro
sfm
thermo
scientif
supplement
mm
lglutamin
antibioticsantimycot
thermo
scientif
grown
h
c
co
environ
twofold
serial
dilut
scfvhfc
fusion
protein
mix
tcid
merscov
mixtur
incub
min
c
mixtur
ad
vero
cell
tetrad
incub
day
c
co
environ
cytopath
effect
cpe
well
visual
follow
crystal
violet
stain
day
postinfect
ic
valu
calcul
use
doserespons
inhibit
equat
graphpad
prism
graphpad
softwar
la
jolla
ca
usa
scfvhfc
fusion
protein
nm
incub
either
nm
recombin
glycoprotein
fuse
polyhistidin
tag
cterminu
sino
biolog
inc
without
protein
wv
bsa
pb
contain
wv
sodium
azid
fac
buffer
c
h
scfvhfc
irrelev
scfvhfc
fusion
protein
use
posit
neg
control
respect
cell
ad
vbottom
plate
corn
corn
ny
usa
densiti
cell
per
well
mixtur
ad
well
incub
c
h
cell
wash
three
time
fac
buffer
incub
fitclabel
rabbit
antihi
ab
abcam
cambridg
uk
c
h
cell
wash
three
time
fac
buffer
resuspend
pb
subject
analysi
flow
cytometri
use
fac
canto
ii
instrument
bd
bioscienc
san
jose
ca
usa
sampl
cell
assess
data
analyz
use
flowjo
softwar
treestar
ashland
usa
nonnebul
nebul
sampl
analyz
use
water
hplc
system
water
corpor
milford
usa
equip
biosuit
highresolut
sizeexclus
chromatographi
column
mm
mm
sampl
inject
flow
rate
mlmin
mobil
phase
pb
ph
uv
detect
perform
nm
sampl
tray
column
holder
maintain
c
respect
throughout
data
acquisit
molecular
weight
correspond
antibodi
peak
calcul
use
empow
softwar
water
corpor
dl
experi
perform
use
zetas
nano
malvern
panalyt
ltd
malvern
uk
laser
detect
angl
describ
previous
nonnebul
nebul
sampl
analyz
perform
three
acquisit
per
sampl
pb
ph
use
refer
solvent
result
evalu
zetas
softwar
malvern
panalyt
ltd
vero
cell
seed
plate
cellswel
optipro
sfm
supplement
mm
lglutamin
antibioticsantimycot
thermo
scientif
grown
h
c
co
environ
igg
antibodi
serial
dilut
threefold
dulbecco
pb
welgen
mix
equal
volum
cultur
media
contain
pfu
incub
h
c
co
environ
virusantibodi
mixtur
ad
cell
maintain
h
room
temperatur
mixtur
remov
cell
overlaid
agaros
dmem
incub
day
c
co
environ
cell
wash
pb
fix
h
paraformaldehyd
agaros
overlay
remov
cell
monolay
gentli
wash
water
remov
residu
agaros
cell
stain
crystal
violet
solut
plaqu
count
manual
number
plaqu
plot
function
igg
antibodi
concentr
igg
number
plaqu
reduc
compar
absenc
igg
prnt
calcul
use
graphpad
prism
author
declar
conflict
interest
